Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Cyclopentolate

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44336   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    6 result(s) found for: Cyclopentolate. Displaying page 1 of 1.
    EudraCT Number: 2012-001149-42 Sponsor Protocol Number: C-EEG Start Date*: Information not available in EudraCT
    Sponsor Name:Medical Centre Haaglanden
    Full Title: Cyclopentolate induced EEG changes in children
    Medical condition: Adverse events central nervus system after cycloplegics. EEG changes after cyclopentolate 1%
    Disease: Version SOC Term Classification Code Term Level
    14.1 10029205 - Nervous system disorders 10013760 Drug-induced extrapyramidal side effects LLT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2015-000268-32 Sponsor Protocol Number: ZykloTroCyc Start Date*: 2015-08-12
    Sponsor Name:Universitätsklinikum Erlangen
    Full Title: Prospective, open-label, randomised, single-centre, two-arm, parallel-group, cross-over controlled clinical study, phase 4, to investigate the efficacy of tropicamid 0.5% eyedrops compared to cyclo...
    Medical condition: Cycloplegia for objective refraction measurement
    Disease: Version SOC Term Classification Code Term Level
    18.1 10015919 - Eye disorders 10001906 Amblyopia PT
    Population Age: Children, Under 18 Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2007-003483-22 Sponsor Protocol Number: 18430 Start Date*: 2007-11-23
    Sponsor Name:Medisch Centrum Haaglanden
    Full Title: a double blind randomized study on the effectiveness of cyclopentolate 1% and cyclopentolate 1% with tropicamide 1% in dark irided hypermetropic children
    Medical condition: refraction of the eye/ refractive state of the eye
    Disease: Version SOC Term Classification Code Term Level
    9.1 10038264 Refraction disorder LLT
    Population Age: Children, Under 18 Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-021410-34 Sponsor Protocol Number: EOC-2-Opht-2010 Start Date*: 2010-08-12
    Sponsor Name:Medical Centre Haaglanden
    Full Title: A double blind randomized study on the efficacy of cyclopentolate 1% and cyclopentolate 1% with tropicamide 1% in children
    Medical condition: Depth of cycloplegia; changes of astigmatism; recuperation from cycloplegia and mydriasis
    Disease: Version SOC Term Classification Code Term Level
    12.1 10011719 Cycloplegia LLT
    12.1 10011719 Cycloplegia PT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: NL (Completed)
    Trial results: (No results available)
    EudraCT Number: 2021-003373-64 Sponsor Protocol Number: 01-DIMS-2021 Start Date*: 2021-11-22
    Sponsor Name:NOEMI GUEMES VILLAHOZ
    Full Title: POST-MARKETING PARALLEL CLINICAL TRIAL TO DETERMINE THE EFFECTIVENESS AND TOLERABILITY OF DIMS LENSES IN THE CONTROL OF MYOPIA IN PEDIATRIC POPULATION
    Medical condition: MYOPIA IN PEDIATRIC POPULATION
    Disease:
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2019-002535-28 Sponsor Protocol Number: 7343 Start Date*: Information not available in EudraCT
    Sponsor Name:Hôpitaux Universitaires de Strasbourg
    Full Title: Braking effect on myopia with atropine eye drops at 0.01%.
    Medical condition: Myopia
    Disease:
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sun May 18 12:47:12 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA